Jyong Biotech Ltd.
(NASDAQ: MENS)

Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. It offers plant-derived drugs that focus on the treatment of urinary system diseases. The company was founded by Fu Feng Kuo in July 2002 and is headquartered in New Taipei, Taiwan.

26.900

-2.290 (-7.85%)
Range 26.730 - 30.000   (12.23%)
Open 27.000
Previous Close 29.190
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 39,862
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 01:03.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis